Medpace Holdings (MEDP) Change in Accured Expenses (2015 - 2026)

Medpace Holdings (MEDP) has 12 years of Change in Accured Expenses data on file, last reported at $45.0 million in Q2 2026.

• Quarterly Change in Accured Expenses rose 27.13% year-over-year to $45.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $128.6 million (up 355.6% YoY) and the FY2025 annual result came in at $97.1 million, up 475.07% from the prior year.
• Change in Accured Expenses rose to $45.0 million in Q2 2026, from -$1.3 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $45.3 million in Q3 2025 to a low of -$23.2 million in Q1 2025.
• A 5-year average of $16.2 million and a median of $20.7 million in 2022 frame the typical range for Change in Accured Expenses.
• Annual changes were most pronounced in 2023 — Change in Accured Expenses sank 156.48% — and 2025, when it surged 1241.54%.
• Tracing MEDP's Change in Accured Expenses over 5 years: stood at $4.6 million in 2022, then soared by 486.8% to $27.2 million in 2023, then slumped by 89.14% to $2.9 million in 2024, then surged by 1241.54% to $39.6 million in 2025, then climbed by 13.79% to $45.0 million in 2026.
• The last three Change in Accured Expenses figures came in at $45.0 million (Q2 2026), -$1.3 million (Q1 2026), and $39.6 million (Q4 2025), per Business Quant data.